The increased bioavailability of these substances is relative to the size of the nanocarrier.

They have a core that branches out in regular intervals to form a small, spherical, and very dense nanocarrier.

Nanocarrier vehicles ( 20-200 nm in diameter) can transport drugs and other therapeutic molecules.

A nanocarrier is nanomaterial being used as a transport module for another substance, such as a drug.

High acidic environments cause the drug to be released due to the acidic environment degrading the structure of the nanocarrier.

Passive targeting refers to a nanocarrier's ability to travel down a tumor's vascular system, become trapped, and accumulate in the tumor.

The nanostructure consists of a bio well-matched polymeric nanocarrier that facilitates the penetration into the cell without making of toxicity with high effectiveness.

The smaller the nanocarrier, the better the delivery properties and the solubility of the nutraceuticals; the nanocarrier is able to enter the bloodstream easier if smaller.

The foundation of the new system is a "nanostructured lipid nanocarrier," tiny particles much smaller than a speck of dust that are easily inhaled and also readily attach to cancer cells.

In addition to the D3 activities, advanced diagnostic tools such as chip for genomic and proteomic analysis, multifunctional magnetic/fluorescent nanoprobes, nanocarrier for in vivo drug delivery, nanospectroscopies will be developed.

NanoCarrier recently entered into an agreement with GlaxoSmithKline to determine the feasibility of delivering an undisclosed compound using NanoCarrier's proprietary miceller nanoparticle technology.

A Targeted and Adjuvanted Nanocarrier Lowers the Effective Dose of Liposomal Amphotericin B and Enhances Adaptive Immunity in Murine Cutaneous Leishmaniasis.

However, as some important, normal tissues, such as the liver and kidneys, also have fenestrated endothelium, the nanocarrier size (10-100 nm, with greater retention in tumors seen in using larger nanocarriers) and charge (anionic or neutral) must be considered.

The unloaded nano-carrier does not attack the sensitive HCT116 cells.